| Secondary |
| Back Pain |
15.4% |
| Migraine |
10.3% |
| Drug Use For Unknown Indication |
8.6% |
| Hypertension |
6.9% |
| Prophylaxis |
6.9% |
| Infection |
5.7% |
| Bronchospasm |
4.6% |
| Osteoarthritis |
4.6% |
| Renal Colic |
4.6% |
| Product Used For Unknown Indication |
4.0% |
| Multiple Drug Overdose Intentional |
3.4% |
| Pain |
3.4% |
| Pyelonephritis Acute |
3.4% |
| Gastric Ulcer |
2.9% |
| Hyperuricaemia |
2.9% |
| Parkinson's Disease |
2.9% |
| Vomiting |
2.9% |
| Analgesic Therapy |
2.3% |
| Cough |
2.3% |
| Essential Hypertension |
2.3% |
|
| Renal Failure Acute |
15.2% |
| Erythema Multiforme |
10.9% |
| Toxic Epidermal Necrolysis |
10.9% |
| Status Epilepticus |
8.7% |
| Stevens-johnson Syndrome |
8.7% |
| Rash |
6.5% |
| Nausea |
4.3% |
| Petechiae |
4.3% |
| Thrombocytopenic Purpura |
4.3% |
| Troponin Increased |
4.3% |
| Agranulocytosis |
2.2% |
| Bone Marrow Failure |
2.2% |
| Bronchopulmonary Aspergillosis |
2.2% |
| Condition Aggravated |
2.2% |
| Gastrointestinal Haemorrhage |
2.2% |
| Hepatitis |
2.2% |
| Hepatitis Acute |
2.2% |
| Hepatitis Cholestatic |
2.2% |
| Hypokalaemia |
2.2% |
| Hypotension |
2.2% |
|
| Concomitant |
| Pain |
27.6% |
| Osteoporosis |
17.3% |
| Hypertension |
10.6% |
| Drug Use For Unknown Indication |
7.2% |
| Prophylaxis |
6.5% |
| Depression |
3.5% |
| Product Used For Unknown Indication |
3.2% |
| Rheumatoid Arthritis |
3.0% |
| Gastric Disorder |
2.5% |
| Insomnia |
2.5% |
| Analgesic Therapy |
2.4% |
| Lung Neoplasm Malignant |
1.9% |
| Non-small Cell Lung Cancer |
1.8% |
| Anxiety |
1.7% |
| Diabetes Mellitus |
1.7% |
| Atrial Fibrillation |
1.4% |
| Anticoagulant Therapy |
1.3% |
| Nausea |
1.3% |
| Sleep Disorder |
1.3% |
| Back Pain |
1.2% |
|
| Thrombocytopenia |
10.1% |
| Delirium |
9.1% |
| Vomiting |
8.1% |
| Fall |
7.1% |
| Hip Fracture |
6.1% |
| Upper Limb Fracture |
6.1% |
| Device Dislocation |
5.1% |
| Large Intestine Perforation |
5.1% |
| Hepatic Lesion |
4.0% |
| Hepatitis |
4.0% |
| Neutropenia |
4.0% |
| Pain In Extremity |
4.0% |
| Staphylococcal Bacteraemia |
4.0% |
| Subclavian Vein Thrombosis |
4.0% |
| Tremor |
4.0% |
| Abdominal Pain |
3.0% |
| Hepatitis Cholestatic |
3.0% |
| Hepatotoxicity |
3.0% |
| Hip Arthroplasty |
3.0% |
| Oedema Peripheral |
3.0% |
|
| Interacting |
| Migraine |
62.5% |
| Product Used For Unknown Indication |
37.5% |
|
| Dizziness |
50.0% |
| Renal Failure Acute |
50.0% |
|
